Company intelligence / Profile preview

国药集团昆明血液制品

Kunming, Yunnan, China
Ownership
Private
Development stage
Other
01

Overview

Sinopharm Kunming Blood Products is a prominent biopharmaceutical company based in Kunming, China, specializing in the production of plasma-derived medicines. As a subsidiary of Beijing Tiantan Biological Products under the China National Biotec Group (CNBG), it plays a critical role in Sinopharm's blood products division. The company operates a state-of-the-art manufacturing base in Yunnan province, which is one of the largest plasma fractionation facilities in Asia. Its core product portfolio includes human albumin, intravenous immunoglobulin (IVIG), and essential coagulation factors like Factor VIII and Prothrombin Complex. These products are vital for treating conditions such as immunodeficiencies, hemophilia, and various critical care scenarios. The company is integrated into Sinopharm's extensive supply chain, ensuring high standards of safety and efficacy through advanced viral inactivation and purification technologies.

Therapeutic areas
Infectious DiseasesHematologyMetabolic DisordersImmunology
Modalities
BiologicPlasma-derived therapyImmunoglobulinCoagulation factors
Industry
Biotech
02

Partnerships

China National Biotec GroupSinopharm

Beyond the preview

Go deeper on 国药集团昆明血液制品.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 国药集团昆明血液制品.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call